Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepsure
- Development stage
- Unknown
- Lead developer
- Waterley Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Hepsure** is an oral, sugar-free branched-chain amino acid nutritional formulation marketed by Waterley Pharmaceuticals for nutritional support in liver disease, including hepatic encephalopathy. It contains the essential branched-chain amino acids **L-leucine, L-isoleucine, and L-valine**. BCAA supplementation may support skeletal-muscle ammonia detoxification through glutamine formation and help address protein-energy malnutrition and altered nitrogen metabolism associated with cirrhosis and hepatic encephalopathy.
- Brand names
- HepsureHepsure Orange Sugar Free
Beyond the preview
Go deeper on Hepsure.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepsure.